Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Falecalcitriol is a **fluorinated derivative of vitamin D3** that acts as a regulator of calcium metabolism, primarily by stimulating absorption of calcium from the gut and regulating bone mineralization. It belongs to the dihydroxycholecalciferols class and is specifically known as hexafluorocalcitriol due to six fluorine substitutions. Its mechanism of action closely resembles calcitriol, functioning as an agonist at the vitamin D receptor, thereby promoting calcium absorption, modulating bone formation, and regulating parathyroid hormone levels. It is used for conditions such as hyperparathyroidism, osteomalacia, and rickets[9][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on falecalcitriol.